---
title: "AEON Biopharma receives NYSE non-compliance notice"
date: "2025-02-08 00:31:46"
summary: "AEON Biopharma (NYSE:AEON) on Friday said it has received a NYSE notice, stating that the company is not in compliance with the NYSE American company guide requiring a stockholders’ equity of $2 million or more if it has reported losses from continued operations and/or net losses in two of its..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* AEON Biopharma (NYSE:[AEON](https://seekingalpha.com/symbol/AEON "AEON Biopharma, Inc.")) on Friday said it has received a NYSE notice, stating that the company is not in compliance with the NYSE American company guide requiring a stockholders’ equity of $2 million or more if it has reported losses from continued operations and/or net losses in two of its three most recent fiscal years.
* As per the notice, the company, in connection with its non-compliance, must submit a plan to the NYSE Regulation by March 5, 2025, advising of actions it has taken or will take to regain compliance with the continued listing standards by August 3, 2026.
* The company said the notice has no immediate impact on the listing of its shares of common stock, which will continue to be listed and traded on the NYSE American during this period.
* AEON Biopharma said it intends to comply with NYSE American's requests and will submit its plan accordingly.
* AEON closed -8.57% at $0.128.
* Source: [Press Release](https://seekingalpha.com/pr/19995887-aeon-biopharma-inc-receives-notice-of-non-compliance-with-nyse-american-continued-listing)

[seekalpha](https://seekingalpha.com/news/4405303-aeon-biopharma-receives-nys-non-compliance-notice)
